Alexium teams with leading pillow products group
Alexium International Group Ltd (ASX:AJX) has signed a supply agreement with Pegasus Home Fashions, a New Jersey based supplier of pillows to retail channels of distribution.
Under the agreement, Pegasus Home Fashions will use Alexicool® products for top of bed applications, with a focus on pillows.
Alexium holds proprietary patent applications for novel technologies developed to provide flame retardancy for a wide range of materials.
These environmentally friendly flame retardants have applications for several industries and can be customized.
Alexium also develops proprietary products for advanced thermo-regulation utilising phase change materials.
Applications under development include but are not limited to textiles, packaging, electronics, and building materials.
Alexium’s chemical treatments are currently marketed as Alexicool® and Alexiflam®.
Agreement demonstrates increasing brand recognition
The agreement has an initial two-year term and may be automatically renewed for successive one-year terms.
It also specifies the provisions for the commercial relationship, including pricing and supply capabilities, but does not include any terms for exclusivity.
This is important for Alexium given the broad range of global markets it is targeting and the potential to forge relationships with other parties, providing a diversified revenue base by client and industry.
The supply agreement formalises the relationship previously outlined in a Memorandum of Understanding entered into with Pegasus Home Fashions in 2017 and aligns Alexium with an industry leader for a key segment of the bedding market.
Alexium’s management has conducted due diligence on Pegasus Home Fashions and its suppliers, and they are confident with the distribution plan established by Pegasus Home Fashions.
Highlighting the strengthening of its established relationship with Pegasus, Alexium Chief Commercial Officer Allen Reihman said, “Pegasus Home Fashions is a world class manufacturer of pillow products and is committed to providing its customers with products that utilise the best materials and technologies.
‘’We have worked with them since 2017, and we are pleased to see the success of this line of products.’’
Embedding the Alexicool® technology with Pegasus’ top of bed products will ensure their customers have access to products with enhanced cooling properties, as thermal regulation becomes an important requirement of consumers.
Signing the supply agreement is another important milestone for Alexium, as it further demonstrates the increasing brand recognition and demand for the group’s Alexicool® technology from major manufacturers.
Agreement provides earnings predictability
The agreement follows the signing of a supply contract with a multibillion dollar North American manufacturer in March.
Alexium’s shares have increased more than 50% in just over a month as investors have recognised the company’s potential to grow revenues exponentially due to the wide ranging applications of its products.
While big ticket contracts from large corporations and government instrumentalities such as the US Department of Defence can be game changing, relationships with manufacturers of non-discretionary products that are sold into global markets are extremely valuable.
They also provide earnings stability through the cycle when large one-off contracts can produce extreme peaks and troughs in revenue generation.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.